Sökning: "phase 3 trials"
Visar resultat 16 - 20 av 62 avhandlingar innehållade orden phase 3 trials.
16. Climate Change Adaption of Waterworks for Browning Surface Waters : Nano- and Ultrafiltration Membrane Applications for Drinking Water Treatment
Sammanfattning : Natural organic matter (NOM) is found in all surface, ground, and soil waters. During recent decades, reports worldwide show a continuing increase in the color and NOM of the surface water, which has an adverse effect on drinking water purification. For several practical and hygienic reasons, the presence of NOM is undesirable in drinking water. LÄS MER
17. The effectiveness and cost-effectiveness of cognitive behavioral therapy administered in group or via the internet for patients with irritable bowel syndrome
Sammanfattning : Background: Irritable Bowel Syndrome (IBS) is a benign but debilitating disorder. It is the most commonly diagnosed gastrointestinal condition and affects between 7-21% of the world’s population. It is characterized by abdominal pain and altered bowel habits. LÄS MER
18. Cerebral oedema after reperfusion therapy in patients with ischaemic stroke : predictors, outcomes and treatment
Sammanfattning : Introduction: Reperfusion therapy by intravenous thrombolysis (IVT) and/or endovascular thrombectomy (EVT) are established treatments in ischaemic stroke. Cerebral oedema (COED), caused by dysfunction the blood brain barrier (BBB), is common early after acute ischaemic stroke (AIS), can aggravate the symptoms and worsen the prognosis. LÄS MER
19. Motivations and deterrents to take part in an HIV vaccine trial : experiences from study participants in Dar es Salaam, Tanzania
Sammanfattning : Background: As HIV infection continues to be a public health problem, development of an effective preventive HIV vaccine is a priority. For the ultimate development of an AIDS vaccine, clinical trials are being conducted throughout the world. LÄS MER
20. The effect of thrombin inhibitors on coagulation activity and generation of activated protein C
Sammanfattning : The direct thrombin inhibitor inogatran was, in the TRIM trial (n=1209), compared with unfractionated heparin (UFH) concerning the effect on cardiovascular end-points in unstable coronary artery disease. The results in TRIM demonstrated a trend towards a benefit for UFH during the treatment phase, which was reduced after drug withdrawal. LÄS MER